4//SEC Filing
LaCascia Michael 4
Accession 0001562180-22-000749
CIK 0001822462other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 4:26 PM ET
Size
5.6 KB
Accession
0001562180-22-000749
Insider Transaction Report
Form 4
LaCascia Michael
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-26+135,000→ 135,000 totalExercise: $14.87Exp: 2032-01-25→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]The option vested as to 25% of the underlying shares of common stock on January 26, 2023, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.
Documents
Issuer
Foghorn Therapeutics Inc.
CIK 0001822462
Entity typeother
Related Parties
1- filerCIK 0001831755
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 4:26 PM ET
- Size
- 5.6 KB